Clinical Trial Update: Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial sponsored by Fundación Santa Fe de Bogota evaluating a combined oral contraceptive against dienogest for endometrioma size in endomet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Dienogest (dienogest)

Snippet

Sponsor: Fundación Santa Fe de Bogota | Conditions: Endometriosis | Phase 2, Phase 3 | Status: SUSPENDED